BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14627181)

  • 1. Neurofibromatosis type 2.
    Uppal S; Coatesworth AP
    Int J Clin Pract; 2003 Oct; 57(8):698-703. PubMed ID: 14627181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].
    Sabol Z; Kipke-Sabol L; Miklić P; Hajnsek-Propadalo S; Sabol F
    Lijec Vjesn; 2006; 128(9-10):309-16. PubMed ID: 17128670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of vestibular schwannomas.
    Chang LS; Welling DB
    Methods Mol Biol; 2009; 493():163-77. PubMed ID: 18839347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level.
    Neff BA; Welling DB; Akhmametyeva E; Chang LS
    Otol Neurotol; 2006 Feb; 27(2):197-208. PubMed ID: 16436990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 2.
    Evans GR; Lloyd SKW; Ramsden RT
    Adv Otorhinolaryngol; 2011; 70():91-98. PubMed ID: 21358190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing and screening of individuals at risk of NF2.
    Evans DG; Raymond FL; Barwell JG; Halliday D
    Clin Genet; 2012 Nov; 82(5):416-24. PubMed ID: 22098617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type 2 neurofibromatosis without acoustic neuroma].
    Mautner VF; Lindenau M; Köppen J; Hazim W; Kluwe L
    Zentralbl Neurochir; 1995; 56(2):83-7. PubMed ID: 7639047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral vestibular schwannomas in older patients: NF2 or chance?
    Evans DG; Freeman S; Gokhale C; Wallace A; Lloyd SK; Axon P; Ward CL; Rutherford S; King A; Huson SM; Ramsden RT;
    J Med Genet; 2015 Jun; 52(6):422-4. PubMed ID: 25725045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of risk for cancer as a coincidental finding in DNA array investigation.
    Rostasy K; Fauth C; Gautsch K; Laimer I; Krabichler B; Wimmer K; Frühmesser A; Kotzot D; Moshir S
    Clin Genet; 2013 Mar; 83(3):284-7. PubMed ID: 22428932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 2 (NF2): diagnosis and management.
    Lloyd SK; Evans DG
    Handb Clin Neurol; 2013; 115():957-67. PubMed ID: 23931824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of the patient and family with neurofibromatosis 2: a consensus conference statement.
    Evans DG; Baser ME; O'Reilly B; Rowe J; Gleeson M; Saeed S; King A; Huson SM; Kerr R; Thomas N; Irving R; MacFarlane R; Ferner R; McLeod R; Moffat D; Ramsden R
    Br J Neurosurg; 2005 Feb; 19(1):5-12. PubMed ID: 16147576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas.
    Kluwe L; Mautner V; Heinrich B; Dezube R; Jacoby LB; Friedrich RE; MacCollin M
    J Med Genet; 2003 Feb; 40(2):109-14. PubMed ID: 12566519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the literature.
    Ziats CA; Jain L; McLarney B; Vandenboom E; DuPont BR; Rogers C; Sarasua S; Nevado J; Cordisco EL; Phelan K; Boccuto L
    Eur J Med Genet; 2020 Nov; 63(11):104042. PubMed ID: 32822873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selected problems of neurofibromatosis with presentation of a case of multiple intracranial and intramedullary tumors].
    Stachura Z; Zralek C; Siemianowicz S; Kiczka-Zralek M; Zawadzki T; Kluczewska E; Giec-Lorenc A
    Neurol Neurochir Pol; 1998; 32(6):1563-9. PubMed ID: 10358844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
    Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
    Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NF2 haploinsufficiency in NF2-associated polyneuropathy.
    Hanemann CO; Diebold R; Kaufmann D
    Brain Pathol; 2007 Oct; 17(4):371-6. PubMed ID: 17655741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.